Health ❯ Healthcare ❯ Public Health

Drug Safety

Consumer Awareness Fentanyl Contamination Fentanyl Contaminated Substances Counterfeit Medicines Harm Reduction Opioid Alternatives Regulatory Compliance Efficacy Evaluation Reporting Systems Vaccine Alerts Illicit Medications Contaminated Pharmaceuticals Patient Safety Fentanyl Crisis Regulatory Review Generic Drugs Contaminated Products Prescription Practices Cough Syrup Environmental Exposures Counterfeit Medications Therapeutic Justification Xylazine Labeling Changes Adverse Events Illicit Drug Trade Prescription Trends Cough Syrups Adverse Drug Reactions Clinical Trials Self-Medication Risks

FDA Delays Two Drugs in National Priority Voucher Program After Safety, Efficacy Flags

Internal documents show reviewers extended timelines after raising concerns over efficacy metrics, potential abuse risk, including a treatment-related death.

UC San Diego Releases Public GNPS Drug Library to Identify Drug Exposure From Patient Samples